Friday, July 10, 2026

pharma · Cerebral adrenoleukodystrophy (cALD) · Adrenoleukodystrophy

Minoryx Therapeutics

Minoryx Therapeutics trial registry — 4 ClinicalTrials.gov studies with program phase, status, and indication context.

ES HQ
2011 Founded
32 Employees
EMA registrant Type
Company details
Status
Public
HQ
ES
Founded
2011
Employees
32
Programs
4
Drugs
11
Patents
0
Intelligence · Clinical Trials

Minoryx Therapeutics clinical trials

Registry index of 4 ClinicalTrials.gov studies linked to Minoryx Therapeutics programs — each row shows trial ID, program name, phase, status, and indication.

Minoryx Therapeutics trial registry — 4 ClinicalTrials.gov studies with program phase, status, and indication context.

Recent trial activity

4 updates

Latest clinical program signals indexed for Minoryx Therapeutics.

  1. MT-3-01 — Phase 3

    Clinical update
  2. MT-2-04 — Phase 2

    Clinical update
  3. MT-2-02 — Phase 2

    Clinical update
  4. MT-1-02 — Phase 1

    Clinical update

Trial registry

4 studies